Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alvotech

8.55
-0.0950-1.10%
Volume:37.11K
Turnover:318.73K
Market Cap:2.66B
PE:25.21
High:8.68
Open:8.65
Low:8.51
Close:8.64
Loading ...

Alvotech SA expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
06 May

Sector Update: Health Care Stocks Decline Pre-Bell Monday

MT Newswires Live
·
05 May

Alvotech’s SELARSDI Gains FDA Approval for Interchangeability with Stelara

TIPRANKS
·
05 May

Teva, Alvotech Get FDA Approval for Selarsdi's Interchangeablity With Stelara

MT Newswires Live
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi™ (Ustekinumab-Aekn) With Stelara® (Ustekinumab)

THOMSON REUTERS
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

GlobeNewswire
·
05 May

Teva, Alvotech announce FDA approval of interchangeability for SELARSDI

TIPRANKS
·
05 May

Alvotech Sa - Teva, Alvotech Announce FDA Approval of Interchangeability for Selarsdi (Ustekinumab-Aekn) With Stelara (Ustekinumab)

THOMSON REUTERS
·
05 May

Alvotech Sa - Selarsdi Approved for All Indications Matching Stelara

THOMSON REUTERS
·
05 May

Alvotech Sa - Selarsdi Indicated for Psoriasis, Arthritis, Crohn's, Ulcerative Colitis

THOMSON REUTERS
·
05 May

Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi™ (Ustekinumab-Aekn) With Stelara® (Ustekinumab)

THOMSON REUTERS
·
05 May

New Strong Sell Stocks for April 25th

Zacks
·
25 Apr

New Strong Sell Stocks for April 17th

Zacks
·
17 Apr

Nordic Shares Decline; Alvotech Falls Furthest

Dow Jones
·
10 Apr

Alvotech (NASDAQ:ALVO) Just Reported And Analysts Have Been Lifting Their Price Targets

Simply Wall St.
·
30 Mar

Stock Track | Alvotech Plummets 5% as Earnings Per Share Falls Short of Expectations

Stock Track
·
28 Mar

Alvotech Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
28 Mar

Alvotech Achieves Record Revenue Growth in 2024

TIPRANKS
·
28 Mar

Alvotech reports FY24 EPS (87c), one estimate (55c)

TIPRANKS
·
27 Mar

Alvotech sees FY25 revenue $570M-$670M, consensus $629.15M

TIPRANKS
·
27 Mar